EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Boston Scientific Adds $2B in Debt

Boston Scientific, the giant medical device company, said today it has raised $2 billion in a debt financing. The Natick, MA-based company (NYSE: BSX) secured interest rates ranging between 4.5 percent and 7.38 percent on notes that have to be paid back between 2015 and 2040.